Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients. (2015)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dku553
PubMed Identifier: 25630641
Publication URI: http://europepmc.org/abstract/MED/25630641
Type: Journal Article/Review
Volume: 70
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 5
ISSN: 0305-7453